Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

NCT04788953 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

84

Enrollment

OTHER

Sponsor class

Stopped Study was stopped due to funding limitations.

Conditions

Excessive Sleepiness
Shift-work Disorder

Interventions

DRUG: Solriamfetol Oral Tablet
DRUG: Placebo

Sponsor

Charles A. Czeisler, PhD, MD

Collaborators

[object Object]